Search

A phase 3, multicenter, randomized, double-blind, active-comparator-controlled study to evaluate the safety, tolerability, and immunogenicity of V114 in healthy infants (PNEU-PED-EU-1)

Jennifer Peter Kent Richmond RN MBBS MRCP(UK) FRACP Clinical Research Manager Head, Vaccine Trials Group Jennifer.Kent@thekids.org.au Clinical

STARFISH

Stopping Acute Rheumatic Fever Infections to Strengthen Health

Western Australian Child Development Atlas

We know that place, location, and geography can all influence health, wellbeing, and disease, and thus are important factors in policy development and service planning.

What risk does underlying trimethoprim resistance pose for the development of cotrimoxazole-resistant skin infections

Investigating what risk does underlying trimethoprim resistance pose for the development of cotrimoxazole-resistant skin infections.

Every Friday: Child Health Research Seminars 2014

Join our Friday Child Health Research Seminars in 2014 to explore the latest advancements in child health and connect with leading experts.

Perth trial begins on investigational Golden Staph vaccine

Perth researchers are calling for volunteers to help test an investigational vaccine against Staphylococcus aureus (golden staph).

Potential new vaccine for WA's meningococcal threat

Perth researchers are about to trial a new vaccine that could potentially provide protection against the most common form of meningococcal

A Phase 3, randomized, double-blind trial to evaluate the safety and immunogenicity of a 20-valent pneumococcal conjugate vaccine given as a series of 2 infant doses and 1 toddler dose in healthy infants (NeXXstep)

Jennifer Peter Kent Richmond RN MBBS MRCP(UK) FRACP Clinical Research Manager Head, Vaccine Trials Group Jennifer.Kent@thekids.org.au Clinical

Anita Williams

Research Officer, Infectious Diseases Epidemiology

Bernadette Wong

PhD Candidate and Research Assistant